Subtle Medical

Here’s some news to tickle your brain! 🧠 Subtle Medical has been awarded Phase II funding of our #NIH #SBIR grant to expand our #SubtleSYNTH™ technology into brain imaging. This achievement follows the recent FDA clearance of SubtleSYNTH™ for generating synthetic STIR images (SynthSTIRs) for spinal imaging, marking a significant advancement in MRI technology. SubtleSYNTH™ has the potential to revolutionize the speed and efficiency of MRI exams, reducing acquisition time to zero while maintaining clinical quality. With this new phase of funding, we will be extending these benefits to brain imaging, addressing critical needs in diagnostic imaging. This milestone reflects our ongoing commitment to harnessing the power of AI to improve patient care and imaging workflows. We are grateful for the NIH’s support and look forward to continuing our work to make medical imaging faster, safer, and smarter. Full PR here 👉 https://lnkd.in/g8k3uPRY #SubtleMedical #AI #MedicalImaging #SubtleSYNTH #HealthcareInnovation #MRI

We are excited to announce the latest #SubtleMR research published in the American Journal of Neuroradiology by researchers at University of Washington Radiology led by Dr. Mahmud Mossa-Basha. "DANTE-CAIPI Accelerated Contrast-Enhanced 3D T1: Deep learning-based image quality improvement for Vessel Wall MR" Paper: https://lnkd.in/gFwDum99 Key findings: Enhanced IQ: #SubtleMR improved SNR & reduced flow artifacts. Efficiency gain: #AI reduced scan times 36% w/o compromising quality. Clinical Impact: accelerated IVW offers faster protocols with excellent IQ. Industry Impact: (one of) the first IVW AI recon paper This study demonstrates the power of #AI algorithm (#SubtleMR) to both enhance image quality and reduce scan time for intracranial vessel wall (IVW) MRI, particularly in challenging post-contrast scenarios where low SNR and long scan times have historically been a limitation. Mona Kharaji Gador Canton Yin Guo Mohamad Mosi Niranjan Balu Mahmud Mossa-Basha Zechen Zhou

With the recent Series B funding and FDA Clearance of #SubtleSYNTH, we have a LOT to talk about! Come see us at #AHRA24 Booth 1116 to learn how your center can benefit from faster, safer, and smarter medical imaging. #SubtleMR #MRI

With the recent Series B funding and FDA Clearance of #SubtleSYNTH, we have a LOT to talk about! Come see us at #AHRA24 Booth 1116 to learn how your center can benefit from faster, safer, and smarter medical imaging. #SubtleMR #MRI

We are thrilled to be part of Subtle Medical’s mission to revolutionize the medical imaging acquisition industry and contribute to the expansion of their industry-leading technology into the APAC/Korea market. Big congrats to the Team! Enhao GONG Josh Gurewitz, MBA Anna Menyhart-Borroni “With tens of millions of dollars worth of contracts secured from top radiology providers worldwide, Subtle Medical is poised to capture a significant market share of the $35 billion AI-powered radiology market,” said Sean Seoho Lee, Executive Director at Ignite Innovation “Focusing on the image acquisition stage of radiology, rather than the crowded downstream diagnostics market, the company has established itself as a clear category leader. Subtle Medical stands out from its competitors by encompassing multiple imaging modalities beyond just MRI, tapping into a larger market, and enabling partnerships with pharmaceutical companies. Led by a world-class team of AI experts, clinical leaders, and experienced healthcare executives, the company is set to propel substantial growth and continue its impressive trajectory.”

🚀 More Exciting News from Subtle Medical! We are delighted to announce that Subtle Medical's #SeriesB funding has surpassed $30 million, bringing our total financing to over $50 million. This milestone was achieved with the support of Fusion Fund, EnvisionX Capital, BRV Capital Management, Ignite Innovation, and Samsung Ventures, among others. This funding will accelerate our global sales initiatives and the launch of new innovative AI-driven products. Serving over 600 sites globally, we are committed to revolutionizing medical imaging with enhanced quality and efficiency. Thank you to our investors and partners for your continued support. Together, we are paving the way for better healthcare. Read the PR=> https://lnkd.in/g5NWBckp Learn more at www.subtlemedical.com. Lu Zhang Sean Seoho Lee, PhD Jihong Kim 전태우 #HealthcareInnovation #AIMedicalImaging #SeriesBFunding #SubtleMedical

Did you hear? #SubtleSYNTH is FDA cleared! Now you can create synthetic STIR images with zero acquisition time that are interchangeable with conventionally acquired STIR images, reaching a new milestone of #MRI speed. Stop by our booth at #AHRA24 in Orlando Aug 4-7 to witness the magic and learn more. #AI #Deeplearning #Innovation

We have some very exciting news to announce today! Our AI-powered synthetic imaging software, SubtleSYNTH™, has received FDA clearance and is now available for clinical use in the US! 🚀 SubtleSYNTH™ uses deep learning to generate synthetic STIR images from already-acquired T1 and T2 weighted contrasts, creating STIR images with zero acquisition time that are interchangeable with conventionally acquired STIR images. This is an industry first, and we thank all of the members on the @SubtleMedical team and the clinical partners who helped us reach this milestone. This is just the start, as we explore plans to expand to Brain and MSK imaging next. Read the full press release below, and be sure to join us at RSNA this year to learn more about how SubtleSYNTH™ and our suite of imaging solutions can redefine your MRI imaging program. https://lnkd.in/g6Hr7uGC #AI #HealthcareInnovation #MedicalImaging #FDAcleared #SubtleSYNTH #SubtleMedical #MRI #Radiology #RSNA2023 #HealthcareTransformation

We are excited to be back at #ASNR24 starting this weekend. Please check out our eposters and oral presentations. We will be diving into everything from synthetic imaging to brain alignment algorithims. We look forward to seeing you at these sessions. DM us to set up a meeting or learn more. Safe travels. #SubtleMR #SubtleSYNTH

Subtle Medical is proud to be one of the few Bessemer Venture Partners Deep Health Seed Fund portfolio companies reshaping healthcare with #AI/#GenAI . Appreciate the support since 2018 from Steve Kraus Morgan Cheatham Andrew Hedin